SS Innovations International (SSII) Change in Account Payables (2022 - 2026)
SS Innovations International's (SSII) quarterly Change in Account Payables came in at -$704764.0 in Q1 2026, down 153.03% year-on-year from $1.3 million in Q1 2025, and down 232.17% quarter-over-quarter from $533226.0 in Q4 2025.
SS Innovations International (SSII) Change in Account Payables (2022 - 2026) Analysis & Trends
SS Innovations International has disclosed Change in Account Payables across 5 years of filings, most recently posting -$704764.0 for Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$704764.0, down 153.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $844018.0 (down 53.47% YoY), and the FY2025 annual result was $2.9 million, up 103.98% from the prior year.
- Change in Account Payables came in at -$704764.0 for Q1 2026 at SS Innovations International, down from $533226.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.5 million in Q2 2025 to a low of -$1.4 million in Q3 2025.
- The 5-year median for Change in Account Payables is $183467.0 (2022), against an average of $297829.7.
- Across the five-year window, Change in Account Payables jumped 11752.61% in 2024 and plunged 313.89% in 2025, its largest moves.
- SS Innovations International's Change in Account Payables stood at -$35973.0 in 2022, then jumped by 604.54% to $181498.0 in 2023, then jumped by 183.07% to $513770.0 in 2024, then increased by 3.79% to $533226.0 in 2025, then slumped by 232.17% to -$704764.0 in 2026.
- The last three Change in Account Payables figures came in at -$704764.0 (Q1 2026), $533226.0 (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | -704,764.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -704,764.00 |
| Mar 31, 2026 | -704,764.00 |
| Dec 31, 2025 | 533,226.00 |
| Dec 31, 2025 | 533,226.00 |
| Sep 30, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 513,770.00 |
| Dec 31, 2024 | 513,770.00 |
| Sep 30, 2024 | 672,239.00 |
| Sep 30, 2024 | 672,239.00 |
| Jun 30, 2024 | -701,262.00 |
| Jun 30, 2024 | -701,262.00 |
| Mar 31, 2024 | 926,083.00 |
| Mar 31, 2024 | 926,083.00 |
| Dec 31, 2023 | 181,498.00 |
| Dec 31, 2023 | 181,498.00 |